CisThera

Posted on May 21, 2012    

CisThera is developing innovative therapeutics to treat cancer, cardiac disease, autoimmune diseases, as well as chronic kidney and liver diseases. The technology licensed from UW is being developed to specifically protect against the tissue damage that occurs as a result of many acute or chronic medical conditions.